Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

Presentation TCT 2020

TCT 074: Comparison of Survival Between Patients With Degenerated Bioprostheses and Aortic Stenosis Underwent With Transcatheter Aortic Valve Replacement

Presenter: Antonio J. Muñoz-Garcia

October 14, 2020

Presentation TCT 2020

TCT 140: Direct Implantation of a Supra-Annular Self-Expanding Bioprostheses has no Impact on One-Year Clinical Outcomes

Presenter: Konstantinos Toutouzas

October 14, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Presenter: Guilherme F. Attizzani

June 20, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Conference News STS 2020

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

Yael L. Maxwell

January 30, 2020

Presentation Live Valves 2019

Failed Aortic Valve Bioprostheses: Valve-in-Valve or Redo-SAVR?

Presenter: Danny Dvir

December 10, 2019

Video

» Interview

SCOPE II: A Randomized Trial of Two Self-expanding TAVR Bioprostheses

October 16, 2020

Video

Failed Aortic Valve Bioprostheses- Valve-in-Valve or Redo-SAVR- - D. Dvir

January 9, 2020

Advertisement

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

TCT 074: Comparison of Survival Between Patients With Degenerated Bioprostheses and Aortic Stenosis Underwent With Transcatheter Aortic Valve Replacement

TCT 140: Direct Implantation of a Supra-Annular Self-Expanding Bioprostheses has no Impact on One-Year Clinical Outcomes

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

For Congenital Heart Disease, SAVR With Bioprosthetic Valve Still Reigns

Failed Aortic Valve Bioprostheses: Valve-in-Valve or Redo-SAVR?

SCOPE II: A Randomized Trial of Two Self-expanding TAVR Bioprostheses

Failed Aortic Valve Bioprostheses- Valve-in-Valve or Redo-SAVR- - D. Dvir

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content